The prevention of early vaccinia-virus-induced cytopathic effects by inhibition of protein synthesis.
D046508:Culture Techniques; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects*; D003609:Dactinomycin / Q000494:pharmacology; D005467:Floxuridine / Q000494:pharmacology; D006358:Hot Temperature; D007211:Indoles / Q000494:pharmacology; D007700:Kinetics; D010649:Phenylalanine / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology*; D011830:Radiation Effects; D013882:Thiosemicarbazones / Q000494:pharmacology; D014466:Ultraviolet Rays; D014616:Vaccinia virus / Q000187:drug effects / Q000378:metabolism* / Q000528:radiation effects; D014764:Viral Proteins / Q000037:antagonists & inhibitors* / Q000096:biosynthesis
D007211:Indoles; D013882:Thiosemicarbazones; D014764:Viral Proteins; D005467:Floxuridine; D003609:Dactinomycin; D010649:Phenylalanine; D011691:Puromycin